The parent study, MEDEX (?Mindfulness, Education, and Exercise for remediation of age-related cognitive decline?) is a 2x2 factorial design RCT to test MBSR and exercise for remediation of age-related cognitive decline. MEDEX is randomizing 580 healthy community-living adults aged 65+ to one of four conditions: MBSR alone, exercise alone, MBSR+exercise, or health education (a control condition). Participants receive these protocolized interventions for 18 months total: a six-month acute period, followed by a 12-month maintenance period. We examine (1) cognitive improvements using a neuropsychological battery including the NIH Toolbox and additional memory assessments; (2) neuroimaging markers of plasticity; (3) individual biological and psychosocial variability that predicts response to the interventions. Our goal in this supplement request is to ensure that MEDEX is a high-quality study, with a diverse participant population. To date, despite our efforts, recruitment of African-americans and Hispanics is below our projections. At our Data and Safety Monitoring Board?s recommendation, we received input from the Recruitment Innovation Center at Vanderbilt. We now request supplemental funds to execute these recommendations for recruiting minorities, thereby improving the diversity of our participant sample. This supplement will make MEDEX more representative of the increasingly diverse older American population.

Public Health Relevance

ABSTRACT The parent study, MEDEX (?Mindfulness, Education, and Exercise for remediation of age-related cognitive decline?) is a 2x2 factorial design RCT to test MBSR and exercise for remediation of age-related cognitive decline. MEDEX is randomizing 580 healthy community-living adults aged 65+ to one of four conditions: MBSR alone, exercise alone, MBSR+exercise, or health education (a control condition). Participants receive these protocolized interventions for 18 months total: a six-month acute period, followed by a 12-month maintenance period. We examine (1) cognitive improvements using a neuropsychological battery including the NIH Toolbox and additional memory assessments; (2) neuroimaging markers of plasticity; (3) individual biological and psychosocial variability that predicts response to the interventions. Our goal in this supplement request is to ensure that MEDEX is a high-quality study, with a diverse participant population. To date, despite our efforts, recruitment of African-americans and Hispanics is below our projections. At our Data and Safety Monitoring Board?s recommendation, we received input from the Recruitment Innovation Center at Vanderbilt. We now request supplemental funds to execute these recommendations for recruiting minorities, thereby improving the diversity of our participant sample. This supplement will make MEDEX more representative of the increasingly diverse older American population.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
3R01AG049369-05S1
Application #
9750960
Study Section
Special Emphasis Panel (ZAG1)
Program Officer
Wagster, Molly V
Project Start
2014-09-30
Project End
2019-05-31
Budget Start
2018-09-15
Budget End
2019-05-31
Support Year
5
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Washington University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Roe, Catherine M; Barco, Peggy P; Head, Denise M et al. (2017) Amyloid Imaging, Cerebrospinal Fluid Biomarkers Predict Driving Performance Among Cognitively Normal Individuals. Alzheimer Dis Assoc Disord 31:69-72
Ramsey, Alex T; Wetherell, Julie Loebach; Depp, Colin et al. (2016) Feasibility and Acceptability of Smartphone Assessment in Older Adults with Cognitive and Emotional Difficulties. J Technol Hum Serv 34:209-223
Moore, Raeanne C; Depp, Colin A; Wetherell, Julie Loebach et al. (2016) Ecological momentary assessment versus standard assessment instruments for measuring mindfulness, depressed mood, and anxiety among older adults. J Psychiatr Res 75:116-23
Lenze, Eric J; Mulsant, Benoit H; Blumberger, Daniel M et al. (2015) Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial. Lancet 386:2404-12
Lenze, Eric J (2015) Solving the Geriatric Mental Health Crisis in the 21st Century. JAMA Psychiatry 72:967-8